Yimin Hu, Xiaoyu Liu, Yuping Hu, Weiyan Li, Ning Li
Department of Anesthesiology, Jinling hospital, medical school of Nanjing University, Nanjing, 210002, PR China.
J Cardiothorac Surg. 2013 Mar 16;8:49. doi: 10.1186/1749-8090-8-49.
Vasopressin is widely used to treat various type of hypotension, but the effect of vasopressin on coronary artery bypass grafting surgery (CABG) patients is not clear. This study was to investigate the effect of vasopressin on the hemodynamics in CABG patients.
Twenty coronary artery disease (CAD) patients were randomly divided into two groups: norepinephrine group and vasopressin group. During the anesthesia and the operation, the central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP) were maintained to 8-10cmH2O, and the hemocrit was maintained above 30% through lactate ringer's mixture, artifact colloid and red blood cells. The invasive artery blood pressure (IBP) was maintained by appropriate anesthetic depth and norepinephrine or vasopressin respectively. The target IBP was 70 mmHg, and heart rate (HR) was 60 bpm. The MAP (mean artery pressure), HR, ST-T, CVP, PAP (pulmonary artery pressure), PCWP, SVR (systemic vascular resistance), PVR (pulmonary vascular resistance), CO (cardiac output), urine output, blood gas analysis, surgery duration and blood loss were monitored.
The MAP, HR, and ST-T were stable in either group during the operation. CVP, PCWP and SVR increased but CI deceased during the posterior descending artery (PDA) was grafted in both groups and without any significant difference between them. PAP increased during PDA was grafted in either group and there was significant difference between the two groups. PVR increased during ADA and PDA being grafted in norepinephrine group but not in vasopressin group. Metoprolol usage was 11.2 mg and 5.9 mg in norepinephrine group and vasopressin group respectively.
Vasopressin was better than norepinephrine.to keep the hemodynamics stability of patients undergoing CABG surgery.
血管加压素广泛用于治疗各种类型的低血压,但血管加压素对冠状动脉旁路移植术(CABG)患者的影响尚不清楚。本研究旨在探讨血管加压素对CABG患者血流动力学的影响。
20例冠心病(CAD)患者随机分为两组:去甲肾上腺素组和血管加压素组。在麻醉和手术过程中,中心静脉压(CVP)和肺毛细血管楔压(PCWP)维持在8-10cmH₂O,通过乳酸林格氏液、人工胶体和红细胞使血细胞比容维持在30%以上。分别通过适当的麻醉深度和去甲肾上腺素或血管加压素维持有创动脉血压(IBP)。目标IBP为70 mmHg,心率(HR)为60次/分钟。监测平均动脉压(MAP)、HR、ST-T、CVP、肺动脉压(PAP)、PCWP、体循环血管阻力(SVR)、肺血管阻力(PVR)、心输出量(CO)、尿量、血气分析、手术时间和失血量。
两组手术过程中MAP、HR和ST-T均稳定。两组在移植后降支动脉(PDA)时CVP、PCWP和SVR升高,但心脏指数(CI)降低,两组间无显著差异。两组在移植PDA时PAP均升高,两组间有显著差异。去甲肾上腺素组在移植前降支动脉(ADA)和PDA时PVR升高,而血管加压素组未升高。去甲肾上腺素组和血管加压素组美托洛尔用量分别为11.2 mg和5.9 mg。
血管加压素在维持CABG手术患者血流动力学稳定方面优于去甲肾上腺素。